The following is a list of clinical trials with which the Section of Rheumatology at Dartmouth-Hitchcock Medical Center is currently involved. Talk to your doctor to find out if a clinical trial is right for you.
Rheumatology Clinical Trials
A Multicenter Double-Blind, Randomized Controlled Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects With Psoriatic Arthritis (Amgen Protocol Number (Etanercept) #20130207)
A Long-Term, Open-Label Extension Study Of Tofacitinib (Cp-690,550) For The Treatment Of Psoriatic Arthritis (A3921092)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor (A3921125)
A Randomized, Double-Blind Trial Assessing The Impact Of Methotrexate Discontinuation On The Efficacy Of Subcutaneous Tocilizumab With Methotrexate Therapy (Ml28776)
A Randomized, Double-Blind, Placebo-Controlled, Dose Assessment Phase 2 Study to Evaluate the Safety and Efficacy of CCX168 in Subjects with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study To Assess The Immune Response Following Administration Of Zoster Vaccine To Subjects With Rheumatoid Arthritis Receiving Tofacitinib (Cp-690,550) Or Placebo With Background Methotrexate Treatment
A randomized, double-blind, parallel-group study assessing the efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis
ACR/EULAR endorsed study to develop classification and diagnostic criteria for primary systemic vasculitis
Adenocorticotrophic Hormone for Acute Treatment of Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate.
Biomarkers in Rheumatic Diseases
Using Web-Based Tools To Facilitate Tailored Exercise For People With Osteoarthritis
Validation of VISTA, a Negative Regulator as a Novel Therapy for Autoimmune Disease